Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colorectal Neoplasms (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 1/Phase 2)
Hepatoblastoma (Phase 2)
Leukemia (Phase 1)
Lung Neoplasms (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 1/Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Sarcoma, Ewing (Phase 2)
Wilms Tumor (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue